Bravehaeart Bio
Braveheart Bio is a biotechnology company focused on transforming the standard of care for hypertrophic cardiomyopathy (HCM) and related cardiac conditions. The company develops novel therapeutics, including gene‑editing and small‑molecule approaches, aiming to improve patient outcomes and quality of life. Their platform integrates scientific research, clinical development, and patient advocacy to accelerate innovative treatments for rare heart diseases.
Bravehaeart Bio is profiled on the APIs.io network. Tagged areas include Biotechnology, Cardiology, Rare Disease, Therapeutics, and Gene Editing.
Bravehaeart Bio’s developer surface includes documentation and 8 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Documentation 1
Reference material describing how the API behaves
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API
Other 3
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.